IRCT20200105046010N84招募中Unknown
Bioequivalence study of Indapamide 5.1 mg tablet manufactured by Darou darman Arang versus originator brand in healthy volunteers in the fasted condition
Darou darman Arang0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to Indapamide
研究者
相似试验
招募中
Unknown
Investigating the in vivo bioequivalence of Indapamide 1.5 mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N65Tabriz University of Medical Sciences24
招募中
不适用
Bioequivalence study of Amantadine 100 mg capsuleIn the present study, no diseases will be examined and products will be administered by healthy volunteers.IRCT20210519051345N7Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of Ivabradine 7.5 mg tabletIRCT20200105046010N80Cobel Darou Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of Famotidine 40 mgIRCT20200623047902N14Sanamed pharma company24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tabletIRCT20200105046010N85Tabriz University of Medical Sciences24